A large video clip can be difficult to send over the Internet, and can be difficult for viewers to download... Reducing the frame rate to one-third of the original led to a great reduction in file size, and it reduced the rate at which data had to be sent.
Barring cost issues, new systemic therapies could soon be on the forefront
Biologic therapy yields promising results in treatment of psoriasis, psoriatic arthritis
Option is good choice for psoriasis patients suffering moderate-to-severe plaque disease
New York - While dermatologists need to be aware of legitimate safety issues when prescribing any of the TNF-? antagonists for the treatment of psoriasis, as a bottom line, adalimumab (Humira, Abbott Immunology), etanercept (Enbrel, Amgen/Wyeth), and infliximab (Remicade, Centocor) appear to be safer than some older psoriasis treatments, such as methotrexate and cyclosporine, says Mark Lebwohl, M.D., Sol and Clara Kest Professor and chairman, department of dermatology, Mount Sinai School of Medicine, New York.
Four agents offer safe, effective alternatives to traditional tx for moderate to severe disease
Physician describes switch of patients from oral systemics to biologic therapy
Dallas - For psoriasis patients just starting treatment, as well as those who've had poor results from conventional systemic therapies, biologics are a good first-line treatment option. But what about those who've had good results with methotrexate and cyclosporine and are forced to consider alternatives?
New York - While acitretin remains a common oral treatment for psoriasis, oral tazarotene (Allergan), fumaric acid esters (FAEs), and oral pimecrolimus can cut side effects ranging from alopecia to liver and kidney damage, according to a recent study.
Research shows that less than half of patients with severe psoriasis in the United States receive aggressive treatment - systemic drugs, biologic drugs or phototherapy - for their disease. The total number of severely psoriatic patients has been estimated at 120,000 to 450,000 or more.
Each drug delivers a different level of efficacy and duration and, therefore, requires a different treatment strategy to optimize its impact.
Efficacy, safety encourage use for psoriasis
New York - Results of a retrospective review reinforce the long-term safety and tolerability of repeated treatments with botulinum toxin type A (Botox Cosmetic?, Allergan) for cosmetic reasons, said Alastair Carruthers, M.D., at the American Academy of Dermatology's Academy '04 here recently.
New Orleans - BAY 43-9006, a novel signal transduction inhibitor, has very modest activity as a single agent in melanoma; however, it has promising activity in combination with chemotherapy, investigators said at the annual meeting of the American Society of Clinical Oncology (ASCO).
Charleston, S.C. - Biologic agents for pediatric dermatology offer the promise of being safer and much easier to use than traditional drugs, according to Elaine C. Siegfried, M.D., associate clinical professor of pediatrics and dermatology at St. Louis University School of Medicine, Mo.
New York - When diagnosing a pediatric hair disorder, be sure to examine not only the scalp, but also the skin, nails and even the mouth.
When treating black patients for hair and scalp disorders, clinicians must also have an understanding of hair care practices.
Las Vegas - New technologies are bringing increasingly fine resolution to previously fuzzy images and ideas about disease pathways. That, in turn, is generating better-targeted therapies.
Controversial as they are, the new regulations have focused attention on the complex payroll withholding system that every dermatology practice must deal with.
While all financial ratios are important in determining if a stock may be over- or under-valued, combining the ratios can prove very beneficial.
Firing a patient or terminating the physician-patient relationship (PPR)... requires following a certain protocol in order to be accomplished successfully, without risk of litigation from the patient and/or the family.
Dermatologists and other healthcare providers are soon expected to have a formal mechanism for reporting medical errors and near misses without having to worry that the information will be used against them in a lawsuit.
International report - Some soldiers serving in Iraq say military policies that restrict the wearing of hats during physical training are leaving them unprotected from potentially deadly sun exposure.
New York - Melanoma-derived peptide vaccines are currently an exciting area of melanoma immuno-therapy research, according to Douglas J. Schwartzentruber, M.D., medical director and director of the Center for Cancer Care at Goshen Health System, Goshen, Ind., speaking at the Society of Surgical Oncology annual meeting.
New York - Looking for unusual manifestations of common infections and treating them aggressively are keys to managing infections in immunocompromised patients.
New York-An easy-to-use, self-warming patch containing lidocaine and tetracaine provides effective local anesthesia for minor dermatological procedures in adult patients, said Brian Berman, M.D., Ph.D, at the American Academy of Dermatology's Academy '04 meeting here.
Eilat, Israel - For the last 50 years, hydroquinone has been the reference of treatment in hyperpigmentations, and more recently, combination formulas, peelings and adjuvant therapies including sunscreens containing the drug, show promise. However, topical agents have yet to prove a constant and uncontested efficiency, said Daphne Thioly-Bensoussan M.D., during the 28th Annual Meeting of the Israeli Conference of Dermatology and Venerology.
Clinicians should be aware that unrecognized oral candidiasis is a common underlying cause for recalcitrant vulvar disease.
Kona, Hawaii - Tacrolimus ointment is superior to pimecrolimus cream in treating atopic dermatitis, according to recent trial data reported by Alan Fleischer, M.D., during the 28th Annual Hawaii Dermatology Seminar here. Both calcineurin inhibitors have identical modes of action and identical metabolism, and bind to the same FKBP receptor. "But pimecrolimus has one-third the binding affinity of tacrolimus," he says.
New York - You wouldn't perform a medical procedure without preparation. Nor should you participate in a print or broadcast-media interview without making sure you're ready.
